Follow
Mutation
Mutation: the changing of the structure of a gene, resulting in a variant form that may be transmitted to subsequent generations, caused by the alteration of single base units in DNA, or the deletion, insertion, or rearrangement of larger sections of genes or chromosomes.
OCT 15, 2025 | 10:00 AM
The Cancer Gene Census (CGC) is a widely used module within the Catalogue Of Somatic Mutations In Cancer (COSMIC) that comprises an ongoing effort to catalogue and describe all genes with ca...
SEP 03, 2025 | 10:30 AM
Respiratory viruses continue to pose significant public health challenges globally, including influenza viruses, coronaviruses etc. While existing vaccines have made substantial progress in...
MAY 28, 2025 | 10:00 AM
C.E. CREDITS
As oncology care continues to advance, laboratories are increasingly seeking solutions that offer high-impact, decentralized, and accurate genomic testing. The third session of the Precision...
APR 23, 2025 | 1:00 AM
Finding the right predictive and prognostic biomarkers is essential for improving cancer treatment. In this 30 min webinar, we’ll explore how NGS proteomics, combined with genomics , p...
FEB 04, 2025 | 10:00 AM
When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along wit...
SEP 24, 2024 | 7:00 AM
Human inborn errors of immunity (IEI) comprise a variety of diseases caused by molecular variants that impair both innate and adaptive immune responses. Patients with IEI often exhibit a sus...
SEP 12, 2024 | 8:00 AM
Neoantigens are among the newest promising targets for cancer treatment. Unlike tumor-associated antigens, neoantigens are produced only by tumor cells. These unique molecular markers are hi...
MAY 15, 2024 | 12:00 PM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
MAR 20, 2024 | 8:00 AM
Deciphering somatic mosaicism in healthy tissues and clonal diversity in tumors necessitates single-cell analysis. High-quality genomic and transcriptomic data at the single-cell level depen...
MAR 06, 2024 | 10:00 AM
Join us for a thought-provoking webinar titled, "Breaking Barriers in STI Clinical Management: Addressing Resistance Challenges and Incorporating New Diagnostic Approaches," featur...
FEB 27, 2024 | 10:00 AM
Dr. Christopher E. Mason Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction Digital PCR for...
FEB 27, 2024 10:00am CET, 9:00am GMT
10:00am PT, 12:00pm CT, 1:00pm ET: Welcome 10:15am PT, 12:15pm CT, 1:15pm ET: Digital PCR for minimal residual disease research and cancer research Dr. Christopher E. Mason Professor of Geno...
FEB 27, 2024 9:30am IST, 12:00pm CST/SGT
10:00am PT, 12:00pm CT, 1:00pm ET: Welcome 10:15am PT, 12:15pm CT, 1:15pm ET: Digital PCR for minimal residual disease research and cancer research Dr. Christopher E. Mason Professor of Geno...
FEB 21, 2024 | 6:00 AM
The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity, the pace of development has never been faster. Biopharmaceutical companies can&rsquo...
JAN 16, 2024 | 8:00 AM
The clinical interpretation of genetic testing results remains one of the most significant hurdles in effectively applying genomics in modern medicine. Errors in variant interpretation, whet...
DEC 07, 2023 | 8:00 AM
As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, resea...
NOV 16, 2023 | 10:00 AM
Across various stages of the clinical oncology workflow, from panel design to genomic testing and molecular tumor boards, the identification and validation of actionable genomic alterations...
OCT 24, 2023 | 9:00 AM
DNA comprises molecular information stored in genetic and epigenetic bases, both of which are vital to our understanding of biology in health and disease. The interaction of genetics with th...
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
September 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...
September 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
APR 23, 2025 | 1:00 AM
Finding the right predictive and prognostic biomarkers is essential for improving cancer treatment. In this 30 min webinar, we’ll explore how NGS proteomics, combined with genomics , p...
FEB 04, 2025 | 10:00 AM
When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along wit...
SEP 24, 2024 | 7:00 AM
Human inborn errors of immunity (IEI) comprise a variety of diseases caused by molecular variants that impair both innate and adaptive immune responses. Patients with IEI often exhibit a sus...
SEP 12, 2024 | 8:00 AM
Neoantigens are among the newest promising targets for cancer treatment. Unlike tumor-associated antigens, neoantigens are produced only by tumor cells. These unique molecular markers are hi...
MAY 15, 2024 | 12:00 PM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...